What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Enzyme
Peter Jenner mainly focuses on Parkinson's disease, Internal medicine, Endocrinology, Substantia nigra and Dopamine.
His biological study spans a wide range of topics, including Neuroscience, Mitochondrion and Neurodegeneration.
Endocrinology and Ferritin are frequently intertwined in his study.
His Substantia nigra research includes elements of Lewy body, Oxidative stress, Basal ganglia and Degenerative disease.
His Dopamine research is multidisciplinary, relying on both Anesthesia, Thioridazine, Pharmacology and Homovanillic acid.
The study incorporates disciplines such as Agonist, Apomorphine, Pramipexole, Sulpiride and Dopamine receptor in addition to Pharmacology.
His most cited work include:
- Mitochondrial complex I deficiency in Parkinson's disease. (1730 citations)
- Oxidative stress in Parkinson's disease (1601 citations)
- Mitochondrial complex I deficiency in Parkinson's disease. (1325 citations)
What are the main themes of his work throughout his whole career to date?
Peter Jenner spends much of his time researching Internal medicine, Endocrinology, Dopamine, Pharmacology and Parkinson's disease.
Substantia nigra, Striatum, MPTP, Basal ganglia and Putamen are the primary areas of interest in his Endocrinology study.
His Substantia nigra research incorporates elements of Oxidative stress, Biochemistry and Globus pallidus.
The MPTP study combines topics in areas such as Anesthesia, Dyskinesia, Neurotoxin and Parkinsonism.
His Pharmacology study combines topics in areas such as Haloperidol, Dopamine receptor D2, Stimulation and Sulpiride.
His Parkinson's disease study integrates concerns from other disciplines, such as Neuroscience, Neuroprotection and Degenerative disease.
He most often published in these fields:
- Internal medicine (46.04%)
- Endocrinology (45.51%)
- Dopamine (32.45%)
What were the highlights of his more recent work (between 2008-2021)?
- Parkinson's disease (22.56%)
- Internal medicine (46.04%)
- Pharmacology (30.34%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Parkinson's disease, Internal medicine, Pharmacology, Endocrinology and Dopamine.
His work deals with themes such as Dopaminergic and Neuroscience, which intersect with Parkinson's disease.
His Pharmacology study incorporates themes from Benzamide, Ropinirole, Istradefylline and Apomorphine.
His studies in Endocrinology integrate themes in fields like Glial cell line-derived neurotrophic factor and Homovanillic acid.
His Dopamine research includes themes of Receptor and Partial agonist.
His Dyskinesia research integrates issues from Pramipexole, Anesthesia and MPTP.
Between 2008 and 2021, his most popular works were:
- Non-motor features of Parkinson disease. (442 citations)
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease (409 citations)
- Etiology and pathogenesis of Parkinson's disease. (379 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Dopamine
Parkinson's disease, Pharmacology, Neuroscience, Dopaminergic and Disease are his primary areas of study.
His work in Parkinson's disease covers topics such as Neuroprotection which are related to areas like Mitochondrion, Autophagy, Angiogenesis and Genetically modified mouse.
His research integrates issues of Istradefylline, Sulpiride and 5 ht metabolism in his study of Pharmacology.
In general Neuroscience study, his work on Depression often relates to the realm of Psychomotor disorder, thereby connecting several areas of interest.
The various areas that Peter Jenner examines in his Dopaminergic study include Cerebrospinal fluid and Rasagiline.
Endocrinology and Internal medicine are the subject areas of his Dopamine study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
